Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
Clinical trial NCT03342352 · WITHDRAWN
Trial details
- NCT number
- NCT03342352
- Sponsor
- Incyte Corporation
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2018-04-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.